Listed

Sonoma Pharmaceuticals, Inc.

SNOANasdaqCIK 1367083HealthcareFiscal year ends Mar 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$6.4m, Q1 FY2027
Operating income−$40.0k, Q1 FY2027
Net income−$330.0k, Q1 FY2027
Sonoma Pharmaceuticals, Inc., income statement, quarterly
Line itemUnitQ2 FY20242023-09-30Q3 FY20242023-12-31Q4 FY20242024-03-31Q1 FY20252024-06-30Q2 FY20252024-09-30Q3 FY20252024-12-31Q4 FY20252025-03-31Q1 FY20262025-06-30Q2 FY20262025-09-30Q3 FY20262025-12-31Q4 FY20262026-03-31Q1 FY20272026-06-30
Revenue$k2,731Revenue, Q2 FY2024, three months to 2023-09-30$2.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-07, accession 0001683168-24-007708.Report this figure3,138Revenue, Q3 FY2024, three months to 2023-12-31$3.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-02-05, accession 0001683168-25-000736.Report this figure3,439Revenue, Q4 FY2024, three months to 2024-03-31$3.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-06-17, accession 0001683168-25-004546. Derived: 12-month figure less the 9-month figure.Report this figure3,391Revenue, Q1 FY2025, three months to 2024-06-30$3.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0001683168-25-005753.Report this figure3,579Revenue, Q2 FY2025, three months to 2024-09-30$3.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001683168-25-007938.Report this figure3,564Revenue, Q3 FY2025, three months to 2024-12-31$3.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure3,754Revenue, Q4 FY2025, three months to 2025-03-31$3.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-16, accession 0001683168-26-004871. Derived: 12-month figure less the 9-month figure.Report this figure4,015Revenue, Q1 FY2026, three months to 2025-06-30$4.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure5,604Revenue, Q2 FY2026, three months to 2025-09-30$5.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001683168-25-007938.Report this figure4,349Revenue, Q3 FY2026, three months to 2025-12-31$4.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure5,561Revenue, Q4 FY2026, three months to 2026-03-31$5.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-16, accession 0001683168-26-004871. Derived: 12-month figure less the 9-month figure.Report this figure6,406Revenue, Q1 FY2027, three months to 2026-06-30$6.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure
Cost of revenue$k1,741Cost of revenue, Q2 FY2024, three months to 2023-09-30$1.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-07, accession 0001683168-24-007708.Report this figure1,678Cost of revenue, Q3 FY2024, three months to 2023-12-31$1.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-02-05, accession 0001683168-25-000736.Report this figure2,348Cost of revenue, Q4 FY2024, three months to 2024-03-31$2.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2025-06-17, accession 0001683168-25-004546. Derived: 12-month figure less the 9-month figure.Report this figure2,085Cost of revenue, Q1 FY2025, three months to 2024-06-30$2.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-07, accession 0001683168-25-005753.Report this figure2,218Cost of revenue, Q2 FY2025, three months to 2024-09-30$2.2m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-04, accession 0001683168-25-007938.Report this figure2,294Cost of revenue, Q3 FY2025, three months to 2024-12-31$2.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure2,226Cost of revenue, Q4 FY2025, three months to 2025-03-31$2.2m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-06-16, accession 0001683168-26-004871. Derived: 12-month figure less the 9-month figure.Report this figure2,551Cost of revenue, Q1 FY2026, three months to 2025-06-30$2.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure3,484Cost of revenue, Q2 FY2026, three months to 2025-09-30$3.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-04, accession 0001683168-25-007938.Report this figure2,699Cost of revenue, Q3 FY2026, three months to 2025-12-31$2.7m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure3,380Cost of revenue, Q4 FY2026, three months to 2026-03-31$3.4m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-06-16, accession 0001683168-26-004871. Derived: 12-month figure less the 9-month figure.Report this figure3,829Cost of revenue, Q1 FY2027, three months to 2026-06-30$3.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure
Gross profit$k990Gross profit, Q2 FY2024, three months to 2023-09-30$990.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-07, accession 0001683168-24-007708.Report this figure1,460Gross profit, Q3 FY2024, three months to 2023-12-31$1.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-02-05, accession 0001683168-25-000736.Report this figure1,091Gross profit, Q4 FY2024, three months to 2024-03-31$1.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-06-17, accession 0001683168-25-004546. Derived: 12-month figure less the 9-month figure.Report this figure1,306Gross profit, Q1 FY2025, three months to 2024-06-30$1.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-07, accession 0001683168-25-005753.Report this figure1,361Gross profit, Q2 FY2025, three months to 2024-09-30$1.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-04, accession 0001683168-25-007938.Report this figure1,270Gross profit, Q3 FY2025, three months to 2024-12-31$1.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure1,528Gross profit, Q4 FY2025, three months to 2025-03-31$1.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-06-16, accession 0001683168-26-004871. Derived: 12-month figure less the 9-month figure.Report this figure1,464Gross profit, Q1 FY2026, three months to 2025-06-30$1.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure2,120Gross profit, Q2 FY2026, three months to 2025-09-30$2.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-04, accession 0001683168-25-007938.Report this figure1,650Gross profit, Q3 FY2026, three months to 2025-12-31$1.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure2,181Gross profit, Q4 FY2026, three months to 2026-03-31$2.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-06-16, accession 0001683168-26-004871. Derived: 12-month figure less the 9-month figure.Report this figure2,577Gross profit, Q1 FY2027, three months to 2026-06-30$2.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure
Research and development$k536Research and development, Q2 FY2024, three months to 2023-09-30$536.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0001683168-24-007708.Report this figure601Research and development, Q3 FY2024, three months to 2023-12-31$601.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-02-05, accession 0001683168-25-000736.Report this figure409Research and development, Q4 FY2024, three months to 2024-03-31$409.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-06-17, accession 0001683168-25-004546. Derived: 12-month figure less the 9-month figure.Report this figure470Research and development, Q1 FY2025, three months to 2024-06-30$470.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0001683168-25-005753.Report this figure506Research and development, Q2 FY2025, three months to 2024-09-30$506.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001683168-25-007938.Report this figure427Research and development, Q3 FY2025, three months to 2024-12-31$427.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure411Research and development, Q4 FY2025, three months to 2025-03-31$411.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-06-16, accession 0001683168-26-004871. Derived: 12-month figure less the 9-month figure.Report this figure594Research and development, Q1 FY2026, three months to 2025-06-30$594.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure575Research and development, Q2 FY2026, three months to 2025-09-30$575.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001683168-25-007938.Report this figure557Research and development, Q3 FY2026, three months to 2025-12-31$557.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure545Research and development, Q4 FY2026, three months to 2026-03-31$545.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-06-16, accession 0001683168-26-004871. Derived: 12-month figure less the 9-month figure.Report this figure597Research and development, Q1 FY2027, three months to 2026-06-30$597.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure
Selling, general and administrative$k1,662Selling, general and administrative, Q2 FY2024, three months to 2023-09-30$1.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-07, accession 0001683168-24-007708.Report this figure1,703Selling, general and administrative, Q3 FY2024, three months to 2023-12-31$1.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-02-05, accession 0001683168-25-000736.Report this figure2,091Selling, general and administrative, Q4 FY2024, three months to 2024-03-31$2.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-06-17, accession 0001683168-25-004546. Derived: 12-month figure less the 9-month figure.Report this figure2,009Selling, general and administrative, Q1 FY2025, three months to 2024-06-30$2.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-07, accession 0001683168-25-005753.Report this figure1,705Selling, general and administrative, Q2 FY2025, three months to 2024-09-30$1.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-04, accession 0001683168-25-007938.Report this figure1,874Selling, general and administrative, Q3 FY2025, three months to 2024-12-31$1.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure1,773Selling, general and administrative, Q4 FY2025, three months to 2025-03-31$1.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-06-16, accession 0001683168-26-004871. Derived: 12-month figure less the 9-month figure.Report this figure1,965Selling, general and administrative, Q1 FY2026, three months to 2025-06-30$2.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure1,882Selling, general and administrative, Q2 FY2026, three months to 2025-09-30$1.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-04, accession 0001683168-25-007938.Report this figure1,771Selling, general and administrative, Q3 FY2026, three months to 2025-12-31$1.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure1,987Selling, general and administrative, Q4 FY2026, three months to 2026-03-31$2.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-06-16, accession 0001683168-26-004871. Derived: 12-month figure less the 9-month figure.Report this figure2,020Selling, general and administrative, Q1 FY2027, three months to 2026-06-30$2.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure
Operating income$k(1,208)Operating income, Q2 FY2024, three months to 2023-09-30−$1.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0001683168-24-007708.Report this figure(844)Operating income, Q3 FY2024, three months to 2023-12-31−$844.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-02-05, accession 0001683168-25-000736.Report this figure(1,409)Operating income, Q4 FY2024, three months to 2024-03-31−$1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-06-17, accession 0001683168-25-004546. Derived: 12-month figure less the 9-month figure.Report this figure(1,173)Operating income, Q1 FY2025, three months to 2024-06-30−$1.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0001683168-25-005753.Report this figure(850)Operating income, Q2 FY2025, three months to 2024-09-30−$850.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001683168-25-007938.Report this figure(1,031)Operating income, Q3 FY2025, three months to 2024-12-31−$1.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure(656)Operating income, Q4 FY2025, three months to 2025-03-31−$656.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-06-16, accession 0001683168-26-004871. Derived: 12-month figure less the 9-month figure.Report this figure(1,095)Operating income, Q1 FY2026, three months to 2025-06-30−$1.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure(337)Operating income, Q2 FY2026, three months to 2025-09-30−$337.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001683168-25-007938.Report this figure(678)Operating income, Q3 FY2026, three months to 2025-12-31−$678.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure(351)Operating income, Q4 FY2026, three months to 2026-03-31−$351.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-06-16, accession 0001683168-26-004871. Derived: 12-month figure less the 9-month figure.Report this figure(40.0)Operating income, Q1 FY2027, three months to 2026-06-30−$40.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure
Interest expense$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$k186Income tax, Q2 FY2024, three months to 2023-09-30$186.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-07, accession 0001683168-24-007708.Report this figure(57.0)Income tax, Q3 FY2024, three months to 2023-12-31−$57.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-02-05, accession 0001683168-25-000736.Report this figure(292)Income tax, Q4 FY2024, three months to 2024-03-31−$292.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-06-17, accession 0001683168-25-004546. Derived: 12-month figure less the 9-month figure.Report this figure146Income tax, Q1 FY2025, three months to 2024-06-30$146.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0001683168-25-005753.Report this figure147Income tax, Q2 FY2025, three months to 2024-09-30$147.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001683168-25-007938.Report this figure9.0Income tax, Q3 FY2025, three months to 2024-12-31$9.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure248Income tax, Q4 FY2025, three months to 2025-03-31$248.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-06-16, accession 0001683168-26-004871. Derived: 12-month figure less the 9-month figure.Report this figure(1.0)Income tax, Q1 FY2026, three months to 2025-06-30−$1.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure(197)Income tax, Q2 FY2026, three months to 2025-09-30−$197.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001683168-25-007938.Report this figure(130)Income tax, Q3 FY2026, three months to 2025-12-31−$130.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure84.0Income tax, Q4 FY2026, three months to 2026-03-31$84.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-06-16, accession 0001683168-26-004871. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2027, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure
Net income$k(1,484)Net income, Q2 FY2024, three months to 2023-09-30−$1.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-02-05, accession 0001683168-25-000736.Report this figure(866)Net income, Q3 FY2024, three months to 2023-12-31−$866.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-02-05, accession 0001683168-25-000736.Report this figure(1,067)Net income, Q4 FY2024, three months to 2024-03-31−$1.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-06-17, accession 0001683168-25-004546. Derived: 12-month figure less the 9-month figure.Report this figure(1,143)Net income, Q1 FY2025, three months to 2024-06-30−$1.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure(610)Net income, Q2 FY2025, three months to 2024-09-30−$610.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure(928)Net income, Q3 FY2025, three months to 2024-12-31−$928.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure(776)Net income, Q4 FY2025, three months to 2025-03-31−$776.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-06-16, accession 0001683168-26-004871. Derived: 12-month figure less the 9-month figure.Report this figure(1,241)Net income, Q1 FY2026, three months to 2025-06-30−$1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure(534)Net income, Q2 FY2026, three months to 2025-09-30−$534.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure(819)Net income, Q3 FY2026, three months to 2025-12-31−$819.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure(581)Net income, Q4 FY2026, three months to 2026-03-31−$581.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-06-16, accession 0001683168-26-004871. Derived: 12-month figure less the 9-month figure.Report this figure(330)Net income, Q1 FY2027, three months to 2026-06-30−$330.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure
Diluted EPS$ per share(5.75)Diluted EPS, Q2 FY2024, three months to 2023-09-30−$5.75 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0001683168-24-007708.Report this figure(1.59)Diluted EPS, Q3 FY2024, three months to 2023-12-31−$1.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-02-05, accession 0001683168-25-000736.Report this figurenot reported(1.34)Diluted EPS, Q1 FY2025, three months to 2024-06-30−$1.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0001683168-25-005753.Report this figure(0.59)Diluted EPS, Q2 FY2025, three months to 2024-09-30−$0.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001683168-25-007938.Report this figure(0.63)Diluted EPS, Q3 FY2025, three months to 2024-12-31−$0.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figurenot reported(0.76)Diluted EPS, Q1 FY2026, three months to 2025-06-30−$0.76 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure(0.32)Diluted EPS, Q2 FY2026, three months to 2025-09-30−$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001683168-25-007938.Report this figure(0.48)Diluted EPS, Q3 FY2026, three months to 2025-12-31−$0.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figurenot reported(0.09)Diluted EPS, Q1 FY2027, three months to 2026-06-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure
Basic EPS$ per share(5.75)Basic EPS, Q2 FY2024, three months to 2023-09-30−$5.75 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0001683168-24-007708.Report this figure(1.59)Basic EPS, Q3 FY2024, three months to 2023-12-31−$1.59 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-02-05, accession 0001683168-25-000736.Report this figurenot reported(1.34)Basic EPS, Q1 FY2025, three months to 2024-06-30−$1.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0001683168-25-005753.Report this figure(0.59)Basic EPS, Q2 FY2025, three months to 2024-09-30−$0.59 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001683168-25-007938.Report this figure(0.63)Basic EPS, Q3 FY2025, three months to 2024-12-31−$0.63 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figurenot reported(0.76)Basic EPS, Q1 FY2026, three months to 2025-06-30−$0.76 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure(0.32)Basic EPS, Q2 FY2026, three months to 2025-09-30−$0.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001683168-25-007938.Report this figure(0.48)Basic EPS, Q3 FY2026, three months to 2025-12-31−$0.48 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figurenot reported(0.09)Basic EPS, Q1 FY2027, three months to 2026-06-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure

Balance sheet

Cash and equivalents$5.3m, Q1 FY2027
Shareholders' equity$6.6m, Q1 FY2027
Sonoma Pharmaceuticals, Inc., balance sheet, quarterly
Line itemUnitQ2 FY20242023-09-30Q3 FY20242023-12-31FY20242024-03-31Q1 FY20252024-06-30Q2 FY20252024-09-30Q3 FY20252024-12-31FY20252025-03-31Q1 FY20262025-06-30Q2 FY20262025-09-30Q3 FY20262025-12-31FY20262026-03-31Q1 FY20272026-06-30
Cash and equivalents$m2.1Cash and equivalents, Q2 FY2024, at 2023-09-30$2.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-13, accession 0001683168-23-007982.Report this figure2.4Cash and equivalents, Q3 FY2024, at 2023-12-31$2.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-02-08, accession 0001683168-24-000781.Report this figure3.1Cash and equivalents, FY2024, at 2024-03-31$3.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-06-17, accession 0001683168-25-004546.Report this figure2.6Cash and equivalents, Q1 FY2025, at 2024-06-30$2.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0001683168-24-005371.Report this figure4.1Cash and equivalents, Q2 FY2025, at 2024-09-30$4.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0001683168-24-007708.Report this figure5.2Cash and equivalents, Q3 FY2025, at 2024-12-31$5.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-02-05, accession 0001683168-25-000736.Report this figure5.4Cash and equivalents, FY2025, at 2025-03-31$5.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-06-16, accession 0001683168-26-004871.Report this figure3.6Cash and equivalents, Q1 FY2026, at 2025-06-30$3.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0001683168-25-005753.Report this figure3.0Cash and equivalents, Q2 FY2026, at 2025-09-30$3.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001683168-25-007938.Report this figure2.6Cash and equivalents, Q3 FY2026, at 2025-12-31$2.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure2.4Cash and equivalents, FY2026, at 2026-03-31$2.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure5.3Cash and equivalents, Q1 FY2027, at 2026-06-30$5.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure
Current assets$m11.5Current assets, Q2 FY2024, at 2023-09-30$11.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0001683168-23-007982.Report this figure12.5Current assets, Q3 FY2024, at 2023-12-31$12.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-02-08, accession 0001683168-24-000781.Report this figure12.5Current assets, FY2024, at 2024-03-31$12.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-06-17, accession 0001683168-25-004546.Report this figure11.9Current assets, Q1 FY2025, at 2024-06-30$11.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001683168-24-005371.Report this figure12.2Current assets, Q2 FY2025, at 2024-09-30$12.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0001683168-24-007708.Report this figure12.4Current assets, Q3 FY2025, at 2024-12-31$12.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-02-05, accession 0001683168-25-000736.Report this figure12.6Current assets, FY2025, at 2025-03-31$12.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-06-16, accession 0001683168-26-004871.Report this figure13.1Current assets, Q1 FY2026, at 2025-06-30$13.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0001683168-25-005753.Report this figure12.5Current assets, Q2 FY2026, at 2025-09-30$12.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-04, accession 0001683168-25-007938.Report this figure12.1Current assets, Q3 FY2026, at 2025-12-31$12.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure12.1Current assets, FY2026, at 2026-03-31$12.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure16.3Current assets, Q1 FY2027, at 2026-06-30$16.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure
Total assets$m13.6Total assets, Q2 FY2024, at 2023-09-30$13.6m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0001683168-23-007982.Report this figure14.6Total assets, Q3 FY2024, at 2023-12-31$14.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-02-08, accession 0001683168-24-000781.Report this figure14.7Total assets, FY2024, at 2024-03-31$14.7m. XBRL concept us-gaap:Assets. 10-K filed 2025-06-17, accession 0001683168-25-004546.Report this figure13.7Total assets, Q1 FY2025, at 2024-06-30$13.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001683168-24-005371.Report this figure13.7Total assets, Q2 FY2025, at 2024-09-30$13.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0001683168-24-007708.Report this figure13.7Total assets, Q3 FY2025, at 2024-12-31$13.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-02-05, accession 0001683168-25-000736.Report this figure13.7Total assets, FY2025, at 2025-03-31$13.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-06-16, accession 0001683168-26-004871.Report this figure14.6Total assets, Q1 FY2026, at 2025-06-30$14.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0001683168-25-005753.Report this figure13.9Total assets, Q2 FY2026, at 2025-09-30$13.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-04, accession 0001683168-25-007938.Report this figure13.6Total assets, Q3 FY2026, at 2025-12-31$13.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure14.0Total assets, FY2026, at 2026-03-31$14.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure18.1Total assets, Q1 FY2027, at 2026-06-30$18.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure
Current liabilities$m3.2Current liabilities, Q2 FY2024, at 2023-09-30$3.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0001683168-23-007982.Report this figure3.1Current liabilities, Q3 FY2024, at 2023-12-31$3.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-02-08, accession 0001683168-24-000781.Report this figure3.7Current liabilities, FY2024, at 2024-03-31$3.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-06-17, accession 0001683168-25-004546.Report this figure3.8Current liabilities, Q1 FY2025, at 2024-06-30$3.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001683168-24-005371.Report this figure3.3Current liabilities, Q2 FY2025, at 2024-09-30$3.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0001683168-24-007708.Report this figure3.7Current liabilities, Q3 FY2025, at 2024-12-31$3.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-02-05, accession 0001683168-25-000736.Report this figure4.1Current liabilities, FY2025, at 2025-03-31$4.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-06-16, accession 0001683168-26-004871.Report this figure4.8Current liabilities, Q1 FY2026, at 2025-06-30$4.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0001683168-25-005753.Report this figure4.3Current liabilities, Q2 FY2026, at 2025-09-30$4.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-04, accession 0001683168-25-007938.Report this figure4.2Current liabilities, Q3 FY2026, at 2025-12-31$4.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure4.8Current liabilities, FY2026, at 2026-03-31$4.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure5.4Current liabilities, Q1 FY2027, at 2026-06-30$5.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure
Total liabilities$m8.0Total liabilities, Q2 FY2024, at 2023-09-30$8.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0001683168-23-007982.Report this figure7.9Total liabilities, Q3 FY2024, at 2023-12-31$7.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-02-08, accession 0001683168-24-000781.Report this figure8.6Total liabilities, FY2024, at 2024-03-31$8.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-06-17, accession 0001683168-25-004546.Report this figure8.7Total liabilities, Q1 FY2025, at 2024-06-30$8.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0001683168-24-005371.Report this figure8.3Total liabilities, Q2 FY2025, at 2024-09-30$8.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0001683168-24-007708.Report this figure8.8Total liabilities, Q3 FY2025, at 2024-12-31$8.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-02-05, accession 0001683168-25-000736.Report this figure9.3Total liabilities, FY2025, at 2025-03-31$9.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-06-16, accession 0001683168-26-004871.Report this figure10.5Total liabilities, Q1 FY2026, at 2025-06-30$10.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0001683168-25-005753.Report this figure10.1Total liabilities, Q2 FY2026, at 2025-09-30$10.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-04, accession 0001683168-25-007938.Report this figure10.2Total liabilities, Q3 FY2026, at 2025-12-31$10.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure10.9Total liabilities, FY2026, at 2026-03-31$10.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure11.5Total liabilities, Q1 FY2027, at 2026-06-30$11.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Short-term borrowings$mnot reportednot reported0.3Short-term borrowings, FY2024, at 2024-03-31$323.0k. XBRL concept us-gaap:ShortTermBorrowings. 10-K filed 2025-06-17, accession 0001683168-25-004546.Report this figure0.2Short-term borrowings, Q1 FY2025, at 2024-06-30$204.0k. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2024-08-08, accession 0001683168-24-005371.Report this figure0.1Short-term borrowings, Q2 FY2025, at 2024-09-30$82.0k. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2024-11-07, accession 0001683168-24-007708.Report this figure0.0Short-term borrowings, Q3 FY2025, at 2024-12-31$0. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2025-02-05, accession 0001683168-25-000736.Report this figure0.2Short-term borrowings, FY2025, at 2025-03-31$220.0k. XBRL concept us-gaap:ShortTermBorrowings. 10-K filed 2026-06-16, accession 0001683168-26-004871.Report this figure0.1Short-term borrowings, Q1 FY2026, at 2025-06-30$139.0k. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2025-08-07, accession 0001683168-25-005753.Report this figure0.1Short-term borrowings, Q2 FY2026, at 2025-09-30$56.0k. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2025-11-04, accession 0001683168-25-007938.Report this figure0.0Short-term borrowings, Q3 FY2026, at 2025-12-31$0. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure0.2Short-term borrowings, FY2026, at 2026-03-31$222.0k. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure0.1Short-term borrowings, Q1 FY2027, at 2026-06-30$140.0k. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure
Shareholders' equity$m5.7Shareholders' equity, Q2 FY2024, at 2023-09-30$5.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-02-05, accession 0001683168-25-000736.Report this figure6.7Shareholders' equity, Q3 FY2024, at 2023-12-31$6.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-02-05, accession 0001683168-25-000736.Report this figure6.1Shareholders' equity, FY2024, at 2024-03-31$6.1m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-06-16, accession 0001683168-26-004871.Report this figure5.0Shareholders' equity, Q1 FY2025, at 2024-06-30$5.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure5.4Shareholders' equity, Q2 FY2025, at 2024-09-30$5.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure4.9Shareholders' equity, Q3 FY2025, at 2024-12-31$4.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure4.4Shareholders' equity, FY2025, at 2025-03-31$4.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure4.1Shareholders' equity, Q1 FY2026, at 2025-06-30$4.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure3.8Shareholders' equity, Q2 FY2026, at 2025-09-30$3.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure3.4Shareholders' equity, Q3 FY2026, at 2025-12-31$3.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure3.1Shareholders' equity, FY2026, at 2026-03-31$3.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure6.6Shareholders' equity, Q1 FY2027, at 2026-06-30$6.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure

Cash flow

Operating cash flow−$649.0k, Q1 FY2027
Capital expenditure$2.0k, Q1 FY2027
Sonoma Pharmaceuticals, Inc., cash flow, quarterly
Line itemUnitQ2 FY20242023-09-30Q3 FY20242023-12-31Q4 FY20242024-03-31Q1 FY20252024-06-30Q2 FY20252024-09-30Q3 FY20252024-12-31Q4 FY20252025-03-31Q1 FY20262025-06-30Q2 FY20262025-09-30Q3 FY20262025-12-31Q4 FY20262026-03-31Q1 FY20272026-06-30
Operating cash flow$k(1,231)Operating cash flow, Q2 FY2024, three months to 2023-09-30−$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0001683168-24-007708. Derived: 6-month figure less the 3-month figure.Report this figure(1,104)Operating cash flow, Q3 FY2024, three months to 2023-12-31−$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-02-05, accession 0001683168-25-000736. Derived: 9-month figure less the 6-month figure.Report this figure152Operating cash flow, Q4 FY2024, three months to 2024-03-31$152.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-06-17, accession 0001683168-25-004546. Derived: 12-month figure less the 9-month figure.Report this figure(912)Operating cash flow, Q1 FY2025, three months to 2024-06-30−$912.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0001683168-25-005753.Report this figure354Operating cash flow, Q2 FY2025, three months to 2024-09-30$354.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001683168-25-007938. Derived: 6-month figure less the 3-month figure.Report this figure565Operating cash flow, Q3 FY2025, three months to 2024-12-31$565.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-10, accession 0001683168-26-000889. Derived: 9-month figure less the 6-month figure.Report this figure(95.0)Operating cash flow, Q4 FY2025, three months to 2025-03-31−$95.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-06-16, accession 0001683168-26-004871. Derived: 12-month figure less the 9-month figure.Report this figure(2,015)Operating cash flow, Q1 FY2026, three months to 2025-06-30−$2.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure(635)Operating cash flow, Q2 FY2026, three months to 2025-09-30−$635.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001683168-25-007938. Derived: 6-month figure less the 3-month figure.Report this figure(764)Operating cash flow, Q3 FY2026, three months to 2025-12-31−$764.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-10, accession 0001683168-26-000889. Derived: 9-month figure less the 6-month figure.Report this figure(519)Operating cash flow, Q4 FY2026, three months to 2026-03-31−$519.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-06-16, accession 0001683168-26-004871. Derived: 12-month figure less the 9-month figure.Report this figure(649)Operating cash flow, Q1 FY2027, three months to 2026-06-30−$649.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure
Capital expenditure$k2.0Capital expenditure, Q2 FY2024, three months to 2023-09-30$2.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0001683168-24-007708. Derived: 6-month figure less the 3-month figure.Report this figure1.0Capital expenditure, Q3 FY2024, three months to 2023-12-31$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-02-05, accession 0001683168-25-000736. Derived: 9-month figure less the 6-month figure.Report this figure(18.0)Capital expenditure, Q4 FY2024, three months to 2024-03-31−$18.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-06-17, accession 0001683168-25-004546. Derived: 12-month figure less the 9-month figure.Report this figure5.0Capital expenditure, Q1 FY2025, three months to 2024-06-30$5.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0001683168-25-005753.Report this figure26.0Capital expenditure, Q2 FY2025, three months to 2024-09-30$26.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001683168-25-007938. Derived: 6-month figure less the 3-month figure.Report this figure2.0Capital expenditure, Q3 FY2025, three months to 2024-12-31$2.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-10, accession 0001683168-26-000889. Derived: 9-month figure less the 6-month figure.Report this figure47.0Capital expenditure, Q4 FY2025, three months to 2025-03-31$47.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-06-16, accession 0001683168-26-004871. Derived: 12-month figure less the 9-month figure.Report this figure106Capital expenditure, Q1 FY2026, three months to 2025-06-30$106.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure10.0Capital expenditure, Q2 FY2026, three months to 2025-09-30$10.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001683168-25-007938. Derived: 6-month figure less the 3-month figure.Report this figure47.0Capital expenditure, Q3 FY2026, three months to 2025-12-31$47.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-10, accession 0001683168-26-000889. Derived: 9-month figure less the 6-month figure.Report this figure29.0Capital expenditure, Q4 FY2026, three months to 2026-03-31$29.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-06-16, accession 0001683168-26-004871. Derived: 12-month figure less the 9-month figure.Report this figure2.0Capital expenditure, Q1 FY2027, three months to 2026-06-30$2.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure

Shares

Diluted shares (weighted)3.85m, Q1 FY2027
Sonoma Pharmaceuticals, Inc., shares, quarterly
Line itemUnitQ2 FY20232022-09-30Q3 FY20232022-12-31Q1 FY20242023-06-30Q2 FY20242023-09-30Q3 FY20242023-12-31Q1 FY20252024-06-30Q2 FY20252024-09-30Q3 FY20252024-12-31Q1 FY20262025-06-30Q2 FY20262025-09-30Q3 FY20262025-12-31Q1 FY20272026-06-30
Diluted shares (weighted)k shares3.1Diluted shares (weighted), Q2 FY2023, three months to 2022-09-303,101 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0001683168-23-007982.Report this figure3,107Diluted shares (weighted), Q3 FY2023, three months to 2022-12-313,107,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-02-08, accession 0001683168-24-000781.Report this figure4,936Diluted shares (weighted), Q1 FY2024, three months to 2023-06-304,936,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001683168-24-005371.Report this figure258Diluted shares (weighted), Q2 FY2024, three months to 2023-09-30258,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0001683168-24-007708.Report this figure546Diluted shares (weighted), Q3 FY2024, three months to 2023-12-31546,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-02-05, accession 0001683168-25-000736.Report this figure851Diluted shares (weighted), Q1 FY2025, three months to 2024-06-30851,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0001683168-25-005753.Report this figure1,034Diluted shares (weighted), Q2 FY2025, three months to 2024-09-301,034,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001683168-25-007938.Report this figure1,464Diluted shares (weighted), Q3 FY2025, three months to 2024-12-311,464,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure1,641Diluted shares (weighted), Q1 FY2026, three months to 2025-06-301,641,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure1,646Diluted shares (weighted), Q2 FY2026, three months to 2025-09-301,646,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001683168-25-007938.Report this figure1,713Diluted shares (weighted), Q3 FY2026, three months to 2025-12-311,713,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-10, accession 0001683168-26-000889.Report this figure3,846Diluted shares (weighted), Q1 FY2027, three months to 2026-06-303,846,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure

Shares outstanding: 4.79mShares outstanding, period not labelled, at 2026-08-064,788,425 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001683168-26-006024.Report this figure at Aug 6, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. Listed shows no prices and gives no investment advice.